These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31215891)

  • 21. Efficacy and safety of ivermectin 1% cream in treatment of papulopustular rosacea: results of two randomized, double-blind, vehicle-controlled pivotal studies.
    Stein L; Kircik L; Fowler J; Tan J; Draelos Z; Fleischer A; Appell M; Steinhoff M; Lynde C; Liu H; Jacovella J
    J Drugs Dermatol; 2014 Mar; 13(3):316-23. PubMed ID: 24595578
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An emerging treatment: Topical ivermectin for papulopustular rosacea.
    Abokwidir M; Fleischer AB
    J Dermatolog Treat; 2015; 26(4):379-80. PubMed ID: 25424053
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recalcitrant papulopustular rosacea in an immunocompetent patient responding to combination therapy with oral ivermectin and topical permethrin.
    Allen KJ; Davis CL; Billings SD; Mousdicas N
    Cutis; 2007 Aug; 80(2):149-51. PubMed ID: 17944176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol.
    Huang HP; Hsu CK; Lee JY
    Dermatol Ther; 2021 Mar; 34(2):e14899. PubMed ID: 33605018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The management of rosacea.
    Rebora A
    Am J Clin Dermatol; 2002; 3(7):489-96. PubMed ID: 12180896
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 1% Ivermectin Cream (Soolantra) for the Treatment of Rosacea.
    Scheinfeld N
    Skinmed; 2015; 13(3):222-4. PubMed ID: 26380509
    [No Abstract]   [Full Text] [Related]  

  • 27. Maintenance of remission following successful treatment of papulopustular rosacea with ivermectin 1% cream vs. metronidazole 0.75% cream: 36-week extension of the ATTRACT randomized study.
    Taieb A; Khemis A; Ruzicka T; Barańska-Rybak W; Berth-Jones J; Schauber J; Briantais P; Jacovella J; Passeron T;
    J Eur Acad Dermatol Venereol; 2016 May; 30(5):829-36. PubMed ID: 26691278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [THE RATIONALE FOR THE POSSIBLE ROLE OF DEMODEX FOLLICULORUM IN THE PATHOGENESIS OF ROSACEA].
    Tsiskarishvili T; Katsitadze A; Tsiskarishvili N; Chitanava L
    Georgian Med News; 2019 Feb; (287):95-98. PubMed ID: 30958297
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pityriasis Folliculorum: Response to Topical Ivermectin.
    Darji K; Burkemper NM
    J Drugs Dermatol; 2017 Dec; 16(12):1290-1292. PubMed ID: 29240866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe demodexfolliculorum-associated oculocutaneous rosacea in a girl successfully treated with ivermectin.
    Brown M; Hernández-Martín A; Clement A; Colmenero I; Torrelo A
    JAMA Dermatol; 2014 Jan; 150(1):61-3. PubMed ID: 24284904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pimecrolimus 1% cream for the treatment of steroid-induced rosacea: an 8-week split-face clinical trial.
    Lee DH; Li K; Suh DH
    Br J Dermatol; 2008 May; 158(5):1069-76. PubMed ID: 18363758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [A dog related Demodex spp. infestation in a student: a rare Demodex case].
    Esenkaya Taşbent F; Dik B
    Mikrobiyol Bul; 2018 Apr; 52(2):214-220. PubMed ID: 29933739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of IL-17 in Papulopustular Rosacea and Future Directions.
    Amir Ali A; Vender R; Vender R
    J Cutan Med Surg; 2019; 23(6):635-641. PubMed ID: 31402691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and erythema-directed imaging evaluation of papulo-pustular rosacea with topical ivermectin: a 32 weeks duration study.
    Dall'Oglio F; Lacarrubba F; Luca M; Boscaglia S; Micali G
    J Dermatolog Treat; 2019 Nov; 30(7):703-707. PubMed ID: 30663445
    [No Abstract]   [Full Text] [Related]  

  • 35. Demodex and rosacea revisited.
    Moran EM; Foley R; Powell FC
    Clin Dermatol; 2017; 35(2):195-200. PubMed ID: 28274359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical Ivermectin in the Treatment of Papulopustular Rosacea: A Systematic Review of Evidence and Clinical Guideline Recommendations.
    Ebbelaar CCF; Venema AW; Van Dijk MR
    Dermatol Ther (Heidelb); 2018 Sep; 8(3):379-387. PubMed ID: 29943217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New developments in the treatment of rosacea - role of once-daily ivermectin cream.
    Cardwell LA; Alinia H; Moradi Tuchayi S; Feldman SR
    Clin Cosmet Investig Dermatol; 2016; 9():71-7. PubMed ID: 27051311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ivermectin therapy for papulopustular rosacea and periorificial dermatitis in children: A series of 15 cases.
    Noguera-Morel L; Gerlero P; Torrelo A; Hernández-Martín Á
    J Am Acad Dermatol; 2017 Mar; 76(3):567-570. PubMed ID: 28212765
    [No Abstract]   [Full Text] [Related]  

  • 39. Is permethrin 5% cream effective for rosacea?
    Swenor ME
    J Fam Pract; 2003 Mar; 52(3):183-4. PubMed ID: 12620164
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased density of Demodex folliculorum and evidence of delayed hypersensitivity reaction in subjects with papulopustular rosacea.
    Georgala S; Katoulis AC; Kylafis GD; Koumantaki-Mathioudaki E; Georgala C; Aroni K
    J Eur Acad Dermatol Venereol; 2001 Sep; 15(5):441-4. PubMed ID: 11763386
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.